Loading
Latest filing published 15 May 2020 for CV Sciences, Inc., €4,620.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Paul Blake is a declared insider at 2 companies; the most frequent names are Cephalon Inc and CV Sciences, Inc. We count 6 filings; the first trade dates from 17 February 2006 and the latest from 14 May 2020.
The open-market side counts 1 purchase for €4,620 alongside 5 sales for €433k. Netting one side against the other leaves €428k of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2020: 1 purchase and no sales on the market.
The record was last updated on 15 May 2020 with an open-market purchase (€4,620) in CV Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations